Unleash the Power of Genetics for Characterizing AAV Gene Therapies
8am PDT| 11am EDT| 4pm BST| 5pm CEST
Unleash the potential of genetic analysis technologies in gene therapy development. Join this webinar to explore the scientific advancements and breakthroughs made possible by analytical methods. Discover how these technologies overcome challenges, enabling critical product characterization, safety and regulatory compliance.
Attendees will learn about the power of qPCR, dPCR, Sanger sequencing and fragment analysis, as well as how they complement each other in AAV gene therapy manufacturing. Don't miss this opportunity to gain valuable insights and optimize your gene therapies for successful clinical application.
Register now to dive into the world of genetic analysis and elevate your gene therapy development journey!
Attend this webinar to:
- Understand the pivotal role of analytical methods in gene therapy development
- Explore how qPCR, dPCR, Sanger sequencing and fragment analysis support AAV gene therapy manufacturing
- Gain insights into overcoming challenges in gene therapy development through the application of genetic analysis technologies
